Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancer
Matthew G. Davey, Éanna J. Ryan, Peter McAnena, et al.
Surgical Oncology (2021) Vol. 37, pp. 101531-101531
Closed Access | Times Cited: 24

Showing 24 citing articles:

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
Matthew G. Davey, Seán O. Hynes, Michael J. Kerin, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4455-4455
Open Access | Times Cited: 175
Breast cancer recurrence: factors impacting occurrence and survival
Donald Courtney, Matthew G. Davey, Brian Moloney, et al.
Irish Journal of Medical Science (1971 -) (2022) Vol. 191, Iss. 6, pp. 2501-2510
Open Access | Times Cited: 40
The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment
Matthew G. Davey, Molly Davies, Aoïfe Lowery, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8290-8290
Open Access | Times Cited: 38
Radiomic differentiation of breast cancer molecular subtypes using pre-operative breast imaging – A systematic review and meta-analysis
Matthew G. Davey, Martin S. Davey, Michael R. Boland, et al.
European Journal of Radiology (2021) Vol. 144, pp. 109996-109996
Closed Access | Times Cited: 37
Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery–A systematic review and meta-analysis
Dómhnall J O'Connor, Matthew G. Davey, Laura R. Barkley, et al.
The Breast (2021) Vol. 61, pp. 1-10
Open Access | Times Cited: 37
Clinical utility of the 21-gene assay in predicting response to neoadjuvant endocrine therapy in breast cancer: A systematic review and meta-analysis
Matthew G. Davey, Éanna J. Ryan, Michael R. Boland, et al.
The Breast (2021) Vol. 58, pp. 113-120
Open Access | Times Cited: 35
Evaluating the Role of Circulating MicroRNAs to Aid Therapeutic Decision Making for Neoadjuvant Chemotherapy in Breast Cancer
Matthew G. Davey, Maire Caitlin Casey, Andrew McGuire, et al.
Annals of Surgery (2022) Vol. 276, Iss. 5, pp. 905-912
Open Access | Times Cited: 22
Neoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
Luca Cantini, Dario Trapani, Lorenzo Guidi, et al.
Cancer Treatment Reviews (2023) Vol. 123, pp. 102669-102669
Closed Access | Times Cited: 11
Assessing the clinical utility of pre-operative neutrophil–lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer
Burce Isik, Matthew G. Davey, Alisha Jaffer, et al.
Breast Cancer Research and Treatment (2025)
Open Access
Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer – A retrospective cohort study
Matthew G. Davey, Eoin Kerin, Clara O'Flaherty, et al.
The Breast (2021) Vol. 59, pp. 67-75
Open Access | Times Cited: 27
Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence—A Systematic Review
Luis Bouz Mkabaah, Matthew G. Davey, James C. Lennon, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7115-7115
Open Access | Times Cited: 10
OncotypeDX© Recurrence Score in BRCA mutation carriers: a systematic review and meta-analysis
Matthew G. Davey, Vinitha Richard, Aoïfe Lowery, et al.
European Journal of Cancer (2021) Vol. 154, pp. 209-216
Open Access | Times Cited: 16
Evaluating the Role of Circulating MicroRNAs in Predicting Long-Term Survival Outcomes in Breast Cancer: A Prospective, Multicenter Clinical Trial
Matthew G. Davey, Andrew McGuire, Máire‐Caitlín Casey, et al.
Journal of the American College of Surgeons (2022) Vol. 236, Iss. 2, pp. 317-327
Open Access | Times Cited: 12
Is radiomic MRI a feasible alternative to OncotypeDX® recurrence score testing? A systematic review and meta-analysis
Matthew G. Davey, Martin S. Davey, Éanna J. Ryan, et al.
BJS Open (2021) Vol. 5, Iss. 5
Open Access | Times Cited: 10
Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer
Eoin Kerin, Matthew G. Davey, Ray McLaughlin, et al.
The Breast (2022) Vol. 66, pp. 227-235
Open Access | Times Cited: 6
Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon
Ali Atoui, Maroun Bou Zerdan, Ahmad El Mahmoud, et al.
International Journal of Breast Cancer (2022) Vol. 2022, pp. 1-6
Open Access | Times Cited: 6
Operable breast cancer: How not to worsen the prognosis, especially in triple negative and stage II tumors
Rogério Agenor de Araújo, Felipe Andrés Cordero da Luz, Eduarda da Costa Marinho, et al.
Surgical Oncology (2021) Vol. 38, pp. 101596-101596
Closed Access | Times Cited: 6
Synergistic effects of ozone with doxorubicin on the proliferation, apoptosis and metastatic profile of luminal-B type human breast cancer cell line
Onur Olgaç Karagülle, Asiye Gök Yurttaş
Tissue and Cell (2023) Vol. 85, pp. 102233-102233
Closed Access | Times Cited: 2
A comparative study of the ability of recombinant oncolytic adenovirus, doxorubicin and tamoxifen to inhibit the proliferation of breast cancer cells
Shanzhi Li, Zhuoxin Li, Yiquan Li, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 20, pp. 5222-5234
Open Access | Times Cited: 3
The impact of liver resection on survival for patients with metastatic breast cancer – A systematic review and meta-analysis
Gavin Calpin, Matthew G. Davey, Pádraig Calpin, et al.
The Surgeon (2022) Vol. 21, Iss. 4, pp. 242-249
Open Access | Times Cited: 3
Assessing the clinical utility of preoperative neutrophil-lymphocyte ratio as a predictor of clinicopathological parameters in patients being treated for primary breast cancer
Burce Isik, Matthew G. Davey, Alisha Jaffer, et al.
Research Square (Research Square) (2024)
Open Access
Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDER
Matthew G. Davey, Eoin Kerin, Ray McLaughlin, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 5, pp. 500-507
Open Access | Times Cited: 1
Analysis Predictors of the Outcome of Adjuvant of Hormone Therapy on Estrogen Receptor-positive Breast Cancer in Indonesia
Hardisman Dasman, Wirsma Arif Harahap, Daan Khambri
Open Access Macedonian Journal of Medical Sciences (2021) Vol. 9, Iss. B, pp. 847-851
Open Access | Times Cited: 2
miRNAs as biomarkers breast cancer and their influence on tumor epigenetics
Matthew G. Davey, Nicola Miller
Elsevier eBooks (2023), pp. 173-205
Closed Access
Page 1

Scroll to top